Galectin Therapeutics Inc. News

Latest updates and market news for GALT

2 news

Dec 18 - Dec 24, 2025

Page 1

MT Newswires

5 days ago

Galectin Therapeutics Receives FDA Written Response on Belapectin, Adds $10 Million Credit Line

➖

AI Sentiment

Neutral

5/10

Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027

GlobeNewswire

5 days ago

Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027

📈

AI Sentiment

Highly Positive

8/10

Share this news page

Share on Social Networks: